Precigen Exemplar Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

Precigen Exemplar General Information

Description

Developer of specialized miniature swine models intended for the discovery of human disease mechanisms. The company specializes in animal models that represent human diseases, thereby enabling clinicians to predict in humans the efficacy of those next-generation therapeutics, procedures, and devices.

Contact Information

Formerly Known As
Porcinogen, Exemplar Genetics
Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Corporate Office
  • PO Box 242
  • Sioux Center, IA 51250
  • United States
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • PO Box 242
  • Sioux Center, IA 51250
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Precigen Exemplar Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jul-2014 Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view Precigen Exemplar’s complete valuation and funding history, request access »

Precigen Exemplar Patents

Precigen Exemplar Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190269111-A1 Animal models of cancer Inactive 15-Mar-2013
US-20160143255-A1 Animal models of ataxia-telangiectasia (a-t) Inactive 15-Mar-2013
EP-2967011-B1 Animal models of cancer Active 15-Mar-2013
EP-2967011-A2 Animal models of cancer Active 15-Mar-2013
EP-2967011-A4 Animal models of cancer Active 15-Mar-2013 A01K67/0275
To view Precigen Exemplar’s complete patent history, request access »

Precigen Exemplar Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Precigen Exemplar Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Plains Angels Angel Group Minority
To view Precigen Exemplar’s complete investors history, request access »

Precigen Exemplar Investments (2)

Precigen Exemplar’s most recent deal was a Seed Round with Cytotheryx for . The deal was made on 30-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cytotheryx 30-Jun-2021 Seed Round Biotechnology
Cytotheryx 21-Dec-2018 Joint Venture Biotechnology
To view Precigen Exemplar’s complete investments history, request access »

Precigen Exemplar FAQs

  • When was Precigen Exemplar founded?

    Precigen Exemplar was founded in 2008.

  • Where is Precigen Exemplar headquartered?

    Precigen Exemplar is headquartered in Sioux Center, IA.

  • What is the size of Precigen Exemplar?

    Precigen Exemplar has 13 total employees.

  • What industry is Precigen Exemplar in?

    Precigen Exemplar’s primary industry is Biotechnology.

  • Is Precigen Exemplar a private or public company?

    Precigen Exemplar is a Private company.

  • What is Precigen Exemplar’s current revenue?

    The current revenue for Precigen Exemplar is .

  • Who are Precigen Exemplar’s investors?

    Plains Angels has invested in Precigen Exemplar.

  • When was Precigen Exemplar acquired?

    Precigen Exemplar was acquired on 01-Jul-2014.

  • Who acquired Precigen Exemplar?

    Precigen Exemplar was acquired by Precigen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »